|
Home Services Case Studies Equine Health Meet Our Staff Facility Tour Employment Boarding Stables Links Contact Us
| | | |
Colic • Dental Care • De-Worming • Equine Emergency • Hoof Care • Prenatal Mare Care • Preventative Maint. • PreventiCare • Sheath Cleaning • Strangles • Vax Sumary • Vax Guidelines • Vax Schedule • West Nile Virus | | | SUMMARY OF GUIDELINES FOR VACCINATION OF HORSES | A "standard" vaccination program does not exist. Vaccination is an aid in prevention of infectious diseases. Vaccination programs will not succeed without appropriate managerial changes. Not all animals that receive a vaccine will mount an immunologic response; those that respond will not have equal responses. Vaccines should be selected on the basis of:
demographics of the targeted disease
effects of the disease, should it occur
risks of exposure to the disease
efficacy of vaccination program to reduce problems associated with the disease
cost of appropriate vaccination
potential adverse effects of the vaccination program
All animals in a group should be appropriately vaccinated according to their specific needs. Expectations of the client for the vaccination program should be realistic. Strict attention should be afforded the manufacturers recommendations for storage, handling, and route of administration of the vaccine. For most vaccines, a series of multiple (generally 3) doses must be administered initially to induce protective immunity before booster vaccination can be productive. In order to maximally protect foals during the first few months of life, broodmares should receive booster vaccinations during 4 to 6 weeks before foaling, and it is essential that foals receive an adequate amount of colostrum and absorb colostral antibodies. Foals from appropriately vaccinated mares should receive their initial vaccination against most diseases not sooner than 6 months of age; in endemic areas, vaccination against Eastern Equine Encephalomyelitis should begin at 3 to 4 months of age until additional information indicates otherwise. Adverse reactions should be reported to the manufacturer of the product involved.
|
|